News: Basilea

News

News Subscription

Apr 15. 2016

Basilea reports presentation of isavuconazole and ceftobiprole data at European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)

Read more

Mar 15. 2016

Basilea issues agenda for Annual General Meeting of Shareholders

Read more

Mar 09. 2016

Basilea announces that The Lancet Infectious Diseases published results from the CRESEMBA® (isavuconazole) open-label study for the treatment of mucormycosis

Read more

Mar 04. 2016

Basilea launching antifungal CRESEMBA® (isavuconazole) in Germany

Read more

Mar 03. 2016

Basilea launching antifungal CRESEMBA® (isavuconazole) in the United Kingdom

Read more

Feb 29. 2016

Basilea reports solid 2015 full-year results and is launching CRESEMBA®, its second hospital anti-infective, in Europe

Read more

Jan 22. 2016

GSK informs Basilea that it has elected not to continue its U.S. alitretinoin program

Read more

Dec 29. 2015

Basilea's Head of Global Human Resources, Heidi Mc Daid, to retire and Ursula Eberhardt named as successor

Read more

Dec 28. 2015

Basilea provides clinical program updates

Read more

Dec 19. 2015

Final allocations of Basilea CHF 200 million senior convertible bonds

Read more

previous
1
…
24
25
26
…
32
next